© 2026 Optics and Photonics at Nottingham
43%
56.3%
8.8%
£5m+
Data for 2020-2025 from SciVal
Kocon, Artur; Smith, Stuart J; Morentin, Benito; Callado, Luis F; Carter, Wayne; Rahman, Ruman
Regional profiling reveals a distinct glioblastoma infiltrative margin proteome Journal Article
In: Sci. Rep., vol. 15, no. 1, pp. 24021, 2025.
Abstract | Links | Altmetric | Tags: 2D-PAGE, Glioblastoma, Proteomics, Tandem mass spectrometry
@article{Kocon2025-ay,
title = {Regional profiling reveals a distinct glioblastoma infiltrative margin proteome},
author = {Artur Kocon and Stuart J Smith and Benito Morentin and Luis F Callado and Wayne Carter and Ruman Rahman},
doi = {10.1038/s41598-025-09228-z},
year = {2025},
date = {2025-07-01},
urldate = {2025-07-01},
journal = {Sci. Rep.},
volume = {15},
number = {1},
pages = {24021},
publisher = {Springer Science and Business Media LLC},
abstract = {Isocitrate dehydrogenase wild-type glioblastoma, a malignant
brain tumour of glial origin, confers a poor prognosis with a
median survival of 12 to 16 months from diagnosis. Glioblastomas
are aggressive tumours that rapidly proliferate and diffusely
infiltrate surrounding brain tissue. Current multimodal standard
treatment is typically ineffective and despite gross total
surgical resection, tumours recur with more aggressive
sub-clonal populations of malignant cells. A defining
characteristic of glioblastoma is its highly heterogeneous
nature and acquirement of somatic mutations advantageous to
tumour growth and suppression of apoptotic pathways.
Pathogenesis of malignant brain tumours as well as its mode of
transformation to a more aggressive subtype is still largely
unknown. Although genomic studies have elucidated a plethora of
genetic markers associated with glioblastoma subtypes, only a
few have been utilised in a clinical setting. One of the
emerging approaches to studying glioblastomas is by
investigating how an active proteome contributes to its
aggressive nature. Furthermore, through activation of specific
pathways via post-translational modifications of proteins such
as phosphorylation, glioblastomas create an intricate network of
signalling pathways which favour tumour growth and
proliferation. Here, we investigated the feasibility of diverse
methodological approaches to describe abnormal protein
signalling across distinct intra-tumour regions of primary
glioblastoma tissue, including proliferative core, peripheral
rim, and invasive margin. Whilst we observe a broadly comparable
proteome relative to the human non-diseased brain, we identify
cytoplasmic proteins α-trypsin, actin, apolipoprotein A1
and transthyretin which may putatively be associated with the
GBM infiltrative tumour margin.},
keywords = {2D-PAGE, Glioblastoma, Proteomics, Tandem mass spectrometry},
pubstate = {published},
tppubtype = {article}
}
A part of the University of Nottingham
© 2026 Optics and Photonics at Nottingham. Created for free using WordPress and Kubio